WeForNews | Latest News, Breaking News, News Updates India records highest single-day spike, surpasses China toll | WeForNews | Latest News, Blogs
Connect with us

Disaster

India records highest single-day spike, surpasses China toll

India is currently in the fourth phase of lockdown which is till May 31. Cases spiked at record rate during the lockdown 4.0 that allowed much relaxation.

Published

on

Keralites Middle East Corona

New Delhi, May 29 : India on Friday not only recorded its largest jump in new cases as it added 7,466 new Covid patients in 24 hours, emerging as the ninth worst-hit country in the world by pandemic, but it also surpassed China’s toll of 4,638 so far as it recorded 4,706 deaths.

While China was the first country to report disease last December and recorded over 84,000 total cases so far, India that reported its first case in January end, now has 1,65,799 cases that is more than Turkey’s (1,60,979).

The only good news for India is that it has shown a 42.88 per cent recovery with 71,105 of the patients who contacted the disease being cured and sent back home. In the past one day, 175 deaths were also reported.

Delhi and Tamil Nadu showed jump of around 1,000 cases as Maharashtra continued to contribute a lion’s share, it was still the worst hit state that reported 59,546 cases so far. Tamil Nadu now has 19,372 and Delhi 16,281 cases.

Gujarat reported 15,562 cases, Rajasthan 8,067, Madhya Pradesh 7,453 and Uttar Pradesh 7,170.

Kerala which had almost flatten the curve, is witnessing a surge in the number of COVID-19 cases, there are now 1,088.

Number of cases have spiked in the North East, with Assam having 856 cases.

Other States and UTs have also reported steady increase and West Bengal now has 4,536 cases, Telangana (2,256), Punjab (2,158), Jammu and Kashmir (2,036), Bihar (3,296) and Andhra Pradesh(3,251).

India is currently in the fourth phase of lockdown which is till May 31. Cases spiked at record rate during the lockdown 4.0 that allowed much relaxation.

Cities

Earthquake of magnitude 4.1 strikes Jammu and Kashmir

They said while the tremors caused panic among people, there were no reports of any loss of life or injury or damage to property.

Published

on

Earthquake Strong

Srinagar, Jan 16 : An earthquake of magnitude 4.1 hit Jammu and Kashmir on Saturday, but there was no report of any damage, officials said.

At 10:01 pm, the earthquake struck at a latitude of 33.03 degrees north and a longitude of 75.93 degrees east — 93 kms east of Katra, they added.

The depth of the earthquake was 10 kms, the officials said.

They said while the tremors caused panic among people, there were no reports of any loss of life or injury or damage to property.

Continue Reading

Blog

Covaxin consent form says vax administered without ph-3 trial

The vaccine is first offered to the healthcare workers, frontline workers and those above 50 years of age, followed by the below-50 population with comorbidities, and finally to the remaining population based on disease epidemiology and vaccine availability.

Published

on

By

COVAXIN Corona Covid vaccine

New Delhi, Jan 16 : Amid the vaccinaton drive against Covid-19, it has emerged that there is a separate consent form for those who are administered the ‘Covaxin‘ vaccine manufactured by Bharat Biotech.

The form says that “In phase-1 and phase-2 clinical trial ‘Covaxin’ has demonstrated the ability to produce antibodies against Covid-19, however the clinical efficacy of Covaxin is yet to be established and it is still being studied in phase-3 clinical trial, hence it is important to appreciate that receiving the vaccine does not mean that the other precautions related to Covid-19 should not be followed.”

The form says that in case of any adverse and serious condition, the receiver will be provided utmost care at the health centre and in case of casuality the compensation will be provided by Bharat Biotech.

“The compensation for serious adverse event will be paid by sponsor BBIL if the SAE is proven to be casually related to the vaccine,” it said.

Serious concerns were raised in certain quarters including by opposition parties and Congress leader Manish Tewari has questioned the efficacy of ‘Covaxin’ while the Prime Minister has warned people not to believe in “rumours”.

The world’s biggest vaccination drive come almost a year after the first coronavirus case was detected in India, and since then the deadly virus has claimed over 1.5 lakh lives and infected one crore people. The first case came to the fore on January 30, 2020 in Kerala.

Two vaccines — the Oxford vaccine ‘Covishield’ manufactured by the Serum Institute of India, and indigenously developed ‘Covaxin’ by Bharat Biotech — will be administered to priority groups. So far, the central government has procured 1.1 crore Covishield and 55 lakh Covaxin vaccines at a cost of Rs 200 and Rs 206 per dose, respectively.

In Delhi, which has 81 vaccination sites, ‘Covaxin’ has been allotted to six Centre-run hospitals while 75 Delhi government and private hospitals will receive ‘Covishield’.

The vaccine is first offered to the healthcare workers, frontline workers and those above 50 years of age, followed by the below-50 population with comorbidities, and finally to the remaining population based on disease epidemiology and vaccine availability.

Continue Reading

Disaster

Magnitude 6.7 Earthquake Hits Russia-Mongolia Border Region

The quake was at a depth of 10 kilometers

Published

on

Earthquake Strong

AN earthquake of magnitude 6.7 struck the Russia-Mongolia Border Region on Tuesday, the GFZ German Research Center for Geosciences said.

The quake was at a depth of 10 kilometers, it added.

The epicenter of the earthquake was registered 277 kilometers southwest of the city of Angarsk, in the Russian Irkutsk region, and 30 kilometers from the Mongolian city of Turt, Russian state-owned news agency Sputnik reported. https://bit.ly/2XtgrJs

There were no immediate reports of damage or victims, the report said.

Continue Reading
Advertisement

Most Popular